Comparer des méthodes

	EORTC QLQ-CX24 : Qualité de vie dans le cancer du col de l'utérus	FACT-Ovarian : Évaluation fonctionnelle des thérapies anticancéreuses
Domaine	Oncologie	Oncologie
Famille	Process / pipeline	Process / pipeline
Année d'origine	2006	2001
Auteur d'origine	Greimel, E. R., et al. (EORTC Quality of Life Group)	Basen-Engquist, K., et al. (built on Cella, D. F. FACT-G framework)
Type	Self-report questionnaire	Self-report questionnaire
Source fondatrice	Greimel, E. R., Kuljanic Vlasic, K., Zwahlen, D., Rand, K., Heitz, U., Havsteen, H., et al. (2006). The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24. Acta Oncol, 45(3), 344–351.	Basen-Engquist, K., Bodurka, D. C., Lu, H., Sill, M. W., Thaker, P. H., Deavers, M. T., et al. (2001). Reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian (FACT-O) quality of life instrument. Gynecol Oncol, 89(3), 478–488.
Alias	QLQ-CX24	FACT-O
Apparentées	5	5
Résumé	The EORTC QLQ-CX24 is a 24-item cervical-cancer-specific module designed to complement the EORTC QLQ-C30 core questionnaire. Developed by Greimel et al. in 2006, it measures sexual/vaginal function, body image, lymphedema, neuropathy, and gastrointestinal symptoms specific to cervical cancer and its treatments. It is the standard cervical cancer-specific QoL instrument in international oncology research.	The FACT-Ovarian (FACT-O) is a disease-specific quality-of-life measure for women with ovarian cancer, integrating the 27-item FACT-G core with a 12-item ovarian-specific subscale addressing cancer-related symptoms, sexual function, abdominal distension, and treatment side effects. Validated by Basen-Engquist et al. in 2001, it is a standard endpoint in ovarian cancer clinical trials and supportive care research.